Engineers Gate Manager LP

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1620220 NEW YORK, NY

Position in AUPH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$673,980

-$707,466 QoQ

Shares Held

39,716

-57.4% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#117

of 279 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names. AUPH ranks #73 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$673,980	39,716	-57.4%	Shares	Sole	2026-08-14
2026-03-31	$1,381,446	93,215	-20.7%	Shares	Sole	2026-05-15
2025-12-31	$1,873,853	117,483	+110.5%	Shares	Sole	2026-02-17
2025-09-30	$616,645	55,805	+190.9%	Shares	Sole	2025-11-14
2025-06-30	$162,488	19,184	+82.4%	Shares	Sole	2025-08-14
2024-09-30	$77,111	10,520	-54.1%	Shares	Sole	2024-11-14
2023-12-31	$205,853	22,898	-45.0%	Shares	Sole	2024-02-14
2023-09-30	$323,301	41,609	+148.1%	Shares	Sole	2023-11-14
2023-06-30	$162,323	16,769	-33.4%	Shares	Sole	2023-08-14
2022-06-30	$253,129	25,187	+34.8%	Shares	Sole	2022-08-15
2021-12-31	$427,417	18,689	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.